Preoperative risk assessment for marginal patients requiring pulmonary resection.
Surgical resection remains the mainstay of treatment for pulmonary malignancy. The ability of patients to undergo resection is dependent on the anatomic characteristics of the tumor, and the respiratory and cardiovascular status of the patient. There have been recent advances in our understanding of respiratory function in the patient with marginal lung function that have allowed surgical therapy of lung cancer in patients previously deemed inoperable. This review will define the marginal patients who can safely undergo pulmonary resection.
Burke
J Ryan
JR
Department of Surgery, Emory University, School of Medicine, Georgia, Atlanta, USA.
Duarte
Ignacio G
IG
Thourani
Vinod H
VH
Miller
Joseph I
JI
D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D008297:Male; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000009:adverse effects / Q000379:methods*; D011183:Postoperative Complications / Q000401:mortality; D011300:Preoperative Care / Q000379:methods*; D011379:Prognosis; D012129:Respiratory Function Tests; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome